PTGS2 and cancer: When overexpressed, COX-2-synthesized PGE2 acts as a tumor promoter, regulates tumor angiogenesis [14], and potently alters the phenotype and function of circulating and tumor infiltrating cells, resulting in cancer-associated immunodeficiency [17].